Search

everythinglearnresearchcommunity

for

Search:↓

PDRN may reduce inflammation and complications in revision rhinoplasty for patients with high fibrinogen levels.

Antiandrogen therapies are beneficial for treating skin and hair conditions related to androgen levels.

Curcumin, EGCG, barringtozenol, and finasteride are effective VEGFR inhibitors.

Anti-androgens can help reduce the effects of male hormones on the skin.

JAK inhibitors show promise for treating skin conditions like eczema, hair loss, and psoriasis.

Deferasirox effectively reduces iron overload in ß-thalassemia patients but may cause some manageable side effects.

Antiandrogen therapy is effective and well tolerated for treating women's androgenic disorders like hirsutism, acne, and hair loss.

Tofacitinib and baricitinib are effective and safe for treating severe alopecia areata, especially in younger people.

Inconsistent platelet counts in PRP are due to varying blood volumes, preparation methods, and analyzer types.

The treatments tried did not work for her alopecia areata.

Monoclonal antibodies are often linked to alopecia areata cases.

IMTA can help regrow hair in severe alopecia areata when JAK inhibitors don't work well.

Finasteride reduces prostate cancer risk but may increase high-grade tumors; new drugs and better diagnosis are in development, but funding and industry commitment are challenges.

Long-term use of androgens can help manage Hereditary Angioedema (HAE) but may cause serious side effects, so alternative treatments with fewer side effects are being considered.

5ARIs like finasteride can help prevent prostate cancer and treat BPH, but guidelines should be updated to reflect this.

Tofacitinib successfully treated hair loss in a Crohn's disease patient who previously used adalimumab.

DPCP alone is more effective and safer for treating chronic extensive alopecia areata than combining it with anthralin.

Some acne medications have side effects; doctors should educate patients and may not need to do frequent lab tests for all.

Early treatment with finasteride and minoxidil can effectively reverse hereditary hair loss.

Dutasteride effectively treats benign prostatic hyperplasia, improving symptoms and quality of life.

Atorvastatin reversed memory problems caused by cancer drug trastuzumab and improved its cancer-fighting abilities without causing hair loss.

The FDA warned about safety issues with remdesivir and tofacitinib, finasteride is linked to suicidality, potent topical corticosteroids increase osteoporosis risk, henna can cause hemolysis in G6PD deficiency, chemotherapeutic agents can cause adverse reactions, drug interactions are common in cancer patients, ketamine can reduce at-risk drinking, high dose of anticholinergics increases dementia risk in Parkinson's patients, and prenatal exposure to second-generation antipsychotics increases pregnancy complications.

Oral baricitinib and ruxolitinib are effective and safe for treating alopecia areata.

Oral ritlecitinib and baricitinib are promising treatments for severe alopecia areata due to their balance of effectiveness and safety.

Tildrakizumab showed limited effectiveness in treating chronic alopecia areata in a small group of patients.

Researchers found three different ways drugs work to treat hair loss from alopecia areata and identified key factors for personalized treatment.

Combining DPCP and anthralin helps regrow hair in some alopecia areata patients.

Dutasteride is the most studied alternative drug for androgenetic alopecia, but more high-quality research is needed.